Diacomit Capsule
Product Images NDC 68418-7939

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Diacomit (NDC 68418-7939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocodex, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 mg Capsule Carton (500 mg Cap Carton)

This is a medication called DiAcomIT, with 500mg capsules containing stiripentol, manufactured by Bocoder in France and distributed in the USA by Blocodos. The medication guide should be given to each patient along with the 60 capsules, and the capsules should be swallowed whole with a meal and 2 glasses of water. Dosage and administration information can be found in the full prescribing information. The medication should be stored at 20-25°C in the original package away from light and children.*

FDA Label Image

500 mg Capsule 1 (500mg Cap Label1)

The text is a label of a medication called "Diacomit 500mg" (also known as stiripentol). It includes a lot number (1043002), an instruction to dispense a medication guide to each patient, a warning to pay attention by the pharmacist, and an expiration date (formatted as "MMMYYYY").*

FDA Label Image

500 mg Capsule Label 2 (500mg Cap Label2)

This appears to be a product information for a medication called DIAcCOMIT 500 mg, which is a capsule containing stiripentol. The text includes a request to pharmacists to dispense the enclosed Medication Guide to each patient. There is also a reference to a 60-capsule bottle from BI0CODEX®.*

FDA Label Image

500 mg Capsule Label 3 (500mg Cap Label3)

This is a medication containing 500mg of stiripentol per capsule. It is to be swallowed whole with water during a meal and not opened, broken or chewed. Dosage and administration instructions are provided in the full prescribing information. The medication should be stored in a dry place at temperatures between 20-25°C and kept in the original package to protect from light. Warnings are given to refer to the full prescribing information for further details. The medication should be kept out of reach and sight of children. It is manufactured by Blocodex in Gentilly, France and distributed by Blocodex, Inc. in San Mateo, CA, USA. Trademark rights are used under license.*

FDA Label Image

500 mg Powder Carton (500mg Powder Carton)

This is a medication guide for Diacomit oral suspension, containing 500 mg/packet of stiripentol. The guide is intended for pharmacists to dispense to patients. No additional information is available due to the limited and fragmented nature of the text.*

FDA Label Image

500 mg Powder Label (500mg Powder Label)

Not-Available*

FDA Label Image

Capsule Carton (Cap Carton)

This is a medication guide for DiacomIT 250 mg capsules containing stiripentol as an active ingredient. The guide mentions the dosage, administration and warnings while using these capsules. It also advises the pharmacist to dispense the enclosed medication guide to each patient. The medication is manufactured in France and distributed in the United States. The pack contains 60 capsules and is available by prescription only.*

FDA Label Image

Capsule 1 (Cap Label1)

This is a medication called DiAcoMmIT 250 mg, which is available in capsule form. The lot number and expiration date are provided, as well as a note to pharmacists to provide patients with a medication guide. The medication is manufactured by a company called Biocodex, and the provided code may be a product identifier for tracking purposes.*

FDA Label Image

Capsule 2 (Cap Label2)

The text is a pharmaceutical label for a medication called "DiAcOMIT". It comes in 250mg capsules and contains the active ingredient "stiripentol". There is a note for the pharmacist to provide a medication guide to patients. The label indicates that the medication is prescription-only.*

FDA Label Image

Capsule 3 (Cap Label3)

This is a medication containing 250 mg of stiripentol per capsule. The capsules should be swallowed whole with water during a meal and not opened, broken or chewed. The full prescribing information should be consulted for dosage and administration instructions, as well as warnings. The medication should be stored in a dry place at 20-25°C (68 to 77°F), in the original package and protected from light. It should be kept out of reach of children. The medication is manufactured by Blocodex in France and distributed by Blocodex, Inc. in San Mateo, CA. Trademark rights are used under license.*

FDA Label Image

Figure 1 (Figure1)

This is a table showing the proportion of patients in two groups - Placebo and those taking DIACOMIT S0mg/ke/day - and their percentage reduction from baseline in Tonic-Clonic and Clonic Seizure Frequency. There are also some numbers in the table that appear to be part of the data.*

FDA Label Image

Formula (Formula)

FDA Label Image

Powder Carton (Powder Carton)

This appears to be a label or packaging information for a medication called "Diacomit." It comes in individual 250 mg packets and is mixed with water as an oral suspension. The package contains warnings, dosing instructions, and suggests keeping it out of reach of children. The pharmacist is asked to provide the enclosed medication guide to each patient. "L@x3903018" and "JLiwooviqg" seem to be random strings of characters and do not provide any useful information.*

FDA Label Image

Powder Label (Powder Label)

This is a description for a medication called Diacomit, containing 250 mg of stiripentol, available in a packet of oral suspension. The drug should be taken immediately after mixing in water during a meal. The packet includes dosage and administration information and a warning for phenylketonurics. It is manufactured by Biocodex France and accompanied by trademark rights used under license.*

FDA Label Image

Step 1 (Step1)

FDA Label Image

Step 3 (Step3)

FDA Label Image

Step 4 (Step4)

FDA Label Image

Step 5 (Step5)

FDA Label Image

Step 6 (Step6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.